Antitrust & Trade Regulation, Health Law, International Law & Trade

Health Care Reform Update -- April 2, 2013

by Joseph P. Hammang, Alexander Hecht, Kevin M. Kappel, Tom Koutsoumpas, Jeremy Rabinovitz, Robert C. Skinner | Mintz Levin - Health Law on 4/3/2013

In This Issue: Implementation of the Affordable Care Act (ACA); Other HHS and Federal Regulatory Initiatives; Other Congressional and State Initiatives; Other Health Care News; and Hearings and Mark-Ups...more

No Standing for Illegal Drugs: Third Circuit Limits Antitrust Standing for Foreign Drug Manufacturers Absent FDA Approval

by Bill Devinney | BakerHostetler on 2/7/2013

A Third Circuit panel recently ruled that a foreign drug manufacturer lacks antitrust standing when it could only sell its product in the United States through a distributor....more

It's Your Business Newsletter -- December 2012

by Julia P. Coelho, Timothy R. Deckert, Louis A. Dejoie, Megan F. Luck | McNees Wallace & Nurick LLC on 11/30/2012

In This Issue: ..Export Controls: Increased Enforcement Demands an Effective Export Compliance Program - United States exporters are subject to an extremely complex and often overlapping system of export...more

"The Global Competition Landscape: A Conversation With Sharis Pozen"

by Skadden, Arps, Slate, Meagher & Flom LLP on 10/25/2012

Skadden recently welcomed Sharis A. Pozen, former Acting Assistant Attorney General of the Antitrust Division of the U.S. Department of Justice, as a new partner in the firm’s Washington, D.C. office. Sharis discusses her DOJ...more

Clearance: Proskauer's Quarterly Antitrust Update - Fall 2012

by Proskauer Rose LLP on 10/12/2012

In This Issue: - Exchange Of Employee Wage Information: What Is Permitted Under The Antitrust Laws? - Minn-Chem Maximizes Sherman Act's Reach - The FTC Goes Retro to Win Down South - 7th Circuit Clarifies...more

Criminal Antitrust Update - July 2012

by Patton Boggs LLP on 7/18/2012

In This Issue: - INDUSTRY SCORECARD - CASE NOTE: FINANCIAL DAMAGES MUST BE DECIDED BY JURIES - SEVENTH CIRCUIT TAKES BROAD VIEW OF THE FTAIA ...more

Insurance Antitrust Legal News - May 2012 • Volume 1, Number 1

by Dickinson Wright on 5/3/2012

In this issue: - McCarran Repeal Legislation Passes in the House In late March, legislation that would repeal the health insurance industry’s antitrust exemption, contained in the McCarran Ferguson Act (15 USC...more

European Court Moves to Protect Online Selling

by Reed Smith on 10/21/2011

Following are links to the decision of the European Court in the Pierre Fabre case (referral from the French Court of Appeal) (English version, French version), which concerned an absolute ban on selling products other than...more

Health Headlines - May 16, 2011

by King & Spalding on 5/16/2011

In This Issue: - FTC Bars Texas Physician Group From Joint Price Negotiations - Blue Cross Announces Intention To Participate In Florida Medicaid Program - Court Issues Significant Guidance Concerning When...more

Trade Remedies Are Being Used to Combat Imports of Infringing Medical Devices

by King & Spalding on 5/2/2011

Medical device cases are being filed with increasing frequency at the U.S. International Trade Commission (ITC) to combat infringing imports. In particular, owners of intellectual property rights on medical devices regularly...more

Pharmaceutical Patent Settlements Under Fire on Both Sides of the Atlantic

by Morrison & Foerster LLP on 7/22/2009

In recent weeks, the pharmaceutical industry has been in the crosshairs of antitrust enforcers in the U.S. and in Europe. Specifically, patent litigation settlements in which a brand pharmaceutical manufacturer makes a...more

European Commission's Pharmaceutical Sector Inquiry Report Finds Certain Practices May Delay Entry of Generic Medicines

by Morrison & Foerster LLP on 12/2/2008

On November 28, 2008, the European Commission published its preliminary report and findings in connection with the sector inquiry it launched late last year on competition in the pharmaceutical sector. The Commission...more

European Commission Raids Pharmaceutical Companies to Start Sector Inquiry

by Morrison & Foerster LLP on 1/17/2008

On January 16, 2008, the European Commission launched a sector inquiry into the pharmaceuticals industry by carrying out a series of unannounced inspections of innovative and generic pharmaceutical companies. The targeted...more